Dosage ; see below
Combinations ; - see below
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Lorvas | Torrent Pharmaceuticals Ltd. | Medox Pharmaceuticals Ltd. | 2.5mg | 100 | Tablet | per tablet | KES 1,500 |
| Lorvas | Torrent Pharmaceuticals Ltd. | Medox Pharmaceuticals Ltd. | 1.5mg | 30 | Tablet | per tablet | KES 660.00 |
| Frumeron | Remedica Ltd. | Twokay Chemicals Ltd | 2.5mg | 30 | Tablet | per tablet | KES 360.00 |
| Indapamide More info | |
|---|---|
| Mode Of Action | Inhibition of reabsorption of sodium and chloride ions in the cortical thick ascending limb of the loop of henl? and early distal tubules together with direct antihypertensive effect requiring several days to be manifested |
| Drug Indication | Essential hypertension |
| Precautions | Pregnancy; lactation; monitoring of K+ and uric acid serum levels is recommended, especially in subjects with a predisposition or a sensitivity to hypokalemia and in patients with gout. Although no allergic manifestations have been reported during clinical trials, patients with a history of allergy to sulfonamide derivatives should be closely monitored |
| Contra-Indications | Hypersensitivity to sulfonamides; severe renal failure; hepatic encephalopathy or severe hepatic failure; hypokalemia |
| Side Effects | Hypokalemia; fatigue; orthostatic hypotension; allergic manifestations |
| Dosage | Patients can safely self-medicate themselves when well instructed. A thin layer of the cream is applied with the fingers to warts; the cream is massaged gently into the affected areas until no longer visible. Occlusive dressings or wrappings should not be used. |
| Drug Category | DRUGS ACTI NG ON THE CARDIO-VASCULAR SYSTEM |
| Drug Sub-Category | Thiazides and related diuretics |